CVGCX
Price
$15.76
Change
-$0.02 (-0.13%)
Updated
Sep 20 closing price
GFACX
Price
$66.58
Change
-$0.13 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

CVGCX vs GFACX

Header iconCVGCX vs GFACX Comparison
Open Charts CVGCX vs GFACXBanner chart's image
Calamos Growth C
Price$15.76
Change-$0.02 (-0.13%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$66.58
Change-$0.13 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CVGCX vs GFACX Comparison Chart
Loading...
VS
CVGCX vs. GFACX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVGCX is a StrongBuy and GFACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 290B vs. CVGCX (1.55B). CVGCX (0.00) and GFACX (0.00) have matching dividends . CVGCX was incepted earlier than GFACX: CVGCX (28 years) vs GFACX (24 years). CVGCX is a more actively managed with annual turnover of: 57.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than CVGCX: GFACX (250) vs CVGCX (2500). GFACX annual gain was more profitable for investors over the last year : 28.04 vs. CVGCX (23.13). GFACX return over 5 years is better than : 45.21 vs. CVGCX (-14.11).
CVGCXGFACXCVGCX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years24 years-
Gain YTD22.64621.055108%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B290B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year23.1328.0482%
Returns for 3 years-21.12-3.58590%
Returns for 5 years-14.1145.21-31%
Returns for 10 years-61.0652.57-116%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCCO103.60-1.29
-1.23%
Southern Copper Corp
CVRX9.12-0.13
-1.41%
CVRx
CMC53.27-1.21
-2.22%
Commercial Metals Company
COHU24.79-0.84
-3.28%
Cohu
AVTE1.90-0.08
-4.04%
Aerovate Therapeutics